CanBas Co., Ltd.: peers
CanBas Co., Ltd. beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.
CanBas Co., Ltd., Stella Pharma Corporation, Immuno-Biological Laboratories Co., Ltd., Kubota Pharmaceutical Holdings Co., Ltd., ReproCELL Incorporated, Gene Techno Science, StemRIM Inc., Nanocarrier: the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.
Side by side#
Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.
| Measure | CanBas Co., Ltd.base 4575.T · 🇯🇵 JP Percentile in Healthcare Percentile in Japan | Stella Pharma Corporation 4888.T · 🇯🇵 JP Percentile in Healthcare Percentile in Japan | Immuno-Biological Laboratories Co., Ltd. 4570.T · 🇯🇵 JP Percentile in Healthcare Percentile in Japan | Kubota Pharmaceutical Holdings Co., Ltd. 4596.T · 🇯🇵 JP Percentile in Healthcare Percentile in Japan | ReproCELL Incorporated 4978.T · 🇯🇵 JP Percentile in Healthcare Percentile in Japan | Gene Techno Science 4584.T · 🇯🇵 JP Percentile in Healthcare Percentile in Japan | StemRIM Inc. 4599.T · 🇯🇵 JP Percentile in Healthcare Percentile in Japan | Nanocarrier 4571.T · 🇯🇵 JP Percentile in Healthcare Percentile in Japan | Group median |
|---|---|---|---|---|---|---|---|---|---|
| Size | |||||||||
| Market cap (Better neither way: ranked highest first) | $100 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one4th of 8 | $101 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one3rd of 8 | $89 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one5th of 8 | $88 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one6th of 8 | $115 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one2nd of 8 | $86 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one7th of 8 | $119 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one1st of 8 | $82 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one8th of 8 | $95 M8 ranked |
Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).
Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = CanBas Co., Ltd.: How market caps are worked out; Stella Pharma Corporation: How market caps are worked out; Immuno-Biological Laboratories Co., Ltd.: How market caps are worked out; Kubota Pharmaceutical Holdings Co., Ltd.: How market caps are worked out; ReproCELL Incorporated: How market caps are worked out; Gene Techno Science: How market caps are worked out; StemRIM Inc.: How market caps are worked out; Nanocarrier: How market caps are worked out.
Revenue by fiscal year, and the rank in the group#
Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).
Revenue
Fewer than two years of revenue are on file for these companies.
Rank in the group
Ranks need two fiscal years with the figure for at least two of these companies.
Suggested peers of CanBas Co., Ltd.#
Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.
- Stella Pharma Corporation4888.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $101 M market cap against $100 M · Same country: JapanMarket cap $101 M (last known, Mar 8, 2026)95 of 100 (industry or sector 50 + size 30 + country 15)In the group
- Immuno-Biological Laboratories Co., Ltd.4570.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $89 M market cap against $100 M · Same country: JapanMarket cap $89 M (last known, Mar 8, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- Kubota Pharmaceutical Holdings Co., Ltd.4596.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $88 M market cap against $100 M · Same country: JapanMarket cap $88 M (last known, Mar 8, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- ReproCELL Incorporated4978.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $115 M market cap against $100 M · Same country: JapanMarket cap $115 M (last known, Mar 8, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- Gene Techno Science4584.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $86 M market cap against $100 M · Same country: JapanMarket cap $86 M (last known, Mar 8, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- StemRIM Inc.4599.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $119 M market cap against $100 M · Same country: JapanMarket cap $119 M (last known, Mar 8, 2026) · revenue $19 M (year to July 2020)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- Nanocarrier4571.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $82 M market cap against $100 M · Same country: JapanMarket cap $82 M (last known, Mar 8, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- CellSeed Inc.7776.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $77 M market cap against $100 M · Same country: JapanMarket cap $77 M (last known, Mar 8, 2026)93 of 100 (industry or sector 50 + size 28 + country 15)+ Add
- AnGes, Inc.4563.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $142 M market cap against $100 M · Same country: JapanMarket cap $142 M (last known, Mar 8, 2026) · revenue $0 M (year to December 2020)93 of 100 (industry or sector 50 + size 28 + country 15)+ Add
- RaQualia Pharma Inc.4579.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $148 M market cap against $100 M · Same country: JapanMarket cap $148 M (last known, Mar 8, 2026)92 of 100 (industry or sector 50 + size 27 + country 15)+ Add
- StemCell Institute Inc.7096.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $55 M market cap against $100 M · Same country: JapanMarket cap $55 M (last known, Mar 8, 2026)91 of 100 (industry or sector 50 + size 26 + country 15)+ Add
- Japan Tissue Engineering Co., Ltd.7774.T · 🇯🇵 JapanSame industry: Biotechnology · Similar size: $186 M market cap against $100 M · Same country: JapanMarket cap $186 M (last known, Mar 8, 2026) · revenue $21 M (year to March 2021)91 of 100 (industry or sector 50 + size 26 + country 15)+ Add
Any figure over the years, other peers or a saved group: open this group in the peer workspace.